ID Genomics
company
About
ID Genomics specializes in nucleotide sequence-based molecular diagnostics and epidemiologic analysis of microbial pathogens.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $3M
- Industries
- Biotechnology,Genetics,Health Diagnostics,Medical
- Founded date
- Jan 1, 2012
- Number Of Employee
- 1 - 10
- Operating Status
- Active
ID Genomics specializes in nucleotide sequence-based molecular diagnostics and epidemiologic analysis of microbial pathogens. We provide fast, high-resolution, large- or small-scale clonal identification for clinical microbiology, reference and academic research laboratories, using expanded multi-locus sequence typing (MLST), genome-wide polymorphism annotation, customized phylogenetic and genomic analysis and database creation.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$3.30M
ID Genomics has raised a total of
$3.30M
in funding over 2 rounds. Their latest funding was raised on
Aug 24, 2021 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 24, 2021 | Grant | $300K | 1 |
National Institutes of Health
|
— | Detail |
| May 2, 2016 | Grant | $3M | 1 |
National Institutes of Health
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
1
ID Genomics is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
